References
- Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, . Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09. J Clin Oncol 2010;28:1106–11.
- Mendenhall NP, Li Z, Hoppe BS, Marcus RB, Jr., Mendenhall WM, Nichols RC, . Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:213–21.
- Talcott JA, Rossi C, Shipley WU, Clark JA, Slater JD, Niemierko A, . Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA 2010; 303:1046–53.
- Coen JJ, Paly JJ, Niemierko A, Weyman E, Rodrigues A, Shipley WU, . Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:e201–9.
- Coen JJ, Bae K, Zietman AL, Patel B, Shipley WU, Slater JD, . Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: Initial report of American College of Radiology Phase II study 03–12. Int J Radiat Oncol Biol Phys 2011;81:1005–9.
- Hoppe BS, Nichols RC, Henderson RH, Morris CG, Williams CR, Costa J, . Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer 2012;118:4619–26.
- Malik R, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer: Urinary outcomes for men with high International Prostate Symptom Scores (IPSS). Int J Radiat Oncol Biol Phys 2011;80:1080–6.
- Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA. Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 2000;48:643–7.
- Devisetty K, Zorn KC, Katz MH, Jani AB, Liauw SL. External beam radiation therapy after transurethral resection of the prostate: A report on acute and late genitourinary toxicity. Int J Radiat Oncol Biol Phys 2010;77:1060–5.
- Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, . Quality of life and satisfaction with outcome among prostate-cancer survivors. New Engl J Med 2008;358:1250–61.
- Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, . Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007;109:2239–47.
- Michalski JM, Bae K, Roach M, Markoe AM, Sandler HM, Ryu J, . Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys 2010;76:14–22.
- Spratt DE, Pei X, Yamada J, Kollmeier MA, Cox B, Zelefsky MJ. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys Epub 2012 Jul 12.
- Nihei K, Ogino T, Onozawa M, Murayama S, Fuji H, Murakami M, . Multi-institutional phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys 2011;81:390–6.